Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Why The Dogs Of The Dow Strategy Will Likely Succeed In 2023
05:45am, Tuesday, 03'rd Jan 2023
The "Dogs of the Dow" is a strategy of buying the 10 highest yielding stocks in the Dow (or a subset thereof). The yield spread between the Dogs and the Dow as a whole is larger than usual.
BlackRock, Kimberly-Clark Among 13 Companies To Start 2023 With Annual Dividend Increases
05:51am, Monday, 02'nd Jan 2023
There were several double-digit boosts in December, with Mastercard and Eli Lilly leading the way with 16% and 15% increases, respectively. Abbott Labs began its second half-century of dividend growth
The Dow Stock Dogs Performed In 2022
12:38am, Monday, 02'nd Jan 2023
Very few investment categories generated a positive return in 2022. Over the years, the Dogs of the Dow strategy has generated mixed results, but in a year like 2022, dividends mattered.
2023 Dividend Growth Portfolio Review And Look Ahead
01:30am, Sunday, 01'st Jan 2023
Review of the current holdings and sectors in the portfolio, and how it has changed over the years. Income projections for 2023, and potential pitfalls.
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
Dow Jones Beats S&P 500 in 2022: 5 Hot Stocks
09:47am, Friday, 30'th Dec 2022
The Dow Jones fared as the best of the indexes and five stocks -- Chevron (CVX), Merck (MRK), Travelers (TRV), Amgen (AMGN), and Caterpillar (CAT) -- gained in double-digits in 2022.
These Are The 5 Best Dow Jones Stocks For 2022
01:07pm, Thursday, 29'th Dec 2022
Biotechs, insurers and heavy equipment were among the best Dow Jones stocks for 2022. An oil stock led, even though oil prices declined.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:32am, Thursday, 29'th Dec 2022
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 Unstoppable Dividend Growth Stocks to Buy in 2023 and Beyond
10:07am, Thursday, 29'th Dec 2022
Nothing is more reassuring to an income investor than a boost to the dividend.
FDA Approval, Top Funds Lift Drugmaker In Ailing Market
08:05am, Thursday, 29'th Dec 2022
Boosted by demand among the best mutual funds and an FDA approval, AbbVie shows strength in ailing market. The post FDA Approval, Top Funds Lift Drugmaker In Ailing Market appeared first on Investor's
2 Superstar High-Yield Blue-Chip Buys
07:45am, Thursday, 29'th Dec 2022
Dividend growth blue-chips are the best-performing asset class in history. These two high-yield dividend growth superstars are quintessential Buffett-style "wonderful companies at fair prices."
3 Top Performing Blue-Chips of 2022
04:07pm, Wednesday, 28'th Dec 2022
Many investors have flocked to blue-chip stocks in 2022 to shield themselves from volatility. Can the strength of these three stocks spill into 2023?
The $100,000 Market-Crushing HIGH-Yield Portfolio
09:30am, Wednesday, 28'th Dec 2022
In this article, I discuss my $100,000 high-yield model portfolio, which comes with both a high yield and high dividend growth. The portfolio not only confirms theoretical expectations, but also blows
Jefferies analyst reveals his top two biotech stocks for 2023
07:26pm, Tuesday, 27'th Dec 2022
Moderna Inc (NASDAQ: MRNA) has tanked nearly 15% in recent days but a Jefferies analyst dubs it one of his best ideas for 2023. Moderna stock could climb another 50% Earlier in December, the biotech c
Jefferies' Michael Yee still likes Amgen in the biotech sector
04:35pm, Tuesday, 27'th Dec 2022
Michael Yee, Jefferies biotech analyst, joins 'Closing Bell' to discuss biotech, which is on pace for its worst year since 2016.
